These events were temporally coincident with the initial use of high-dose tranexamic acid ( TXA ) therapy after withdrawal of aprotinin from general clinical usage .
O O O O O O O O O O O B-ChemicalEntity I-ChemicalEntity O B-ChemicalEntity O O O O O O O O O O O